BNTX
BioNTech SE
Company Overview
| Mkt Cap | $25.20B | Price | $104.15 |
| Volume | 626.57K | Change | +0.23% |
| P/E Ratio | -37.9 | Open | $104.80 |
| Revenue | $2.8B | Prev Close | $103.91 |
| Net Income | $-665.3M | 52W Range | $81.20 - $129.27 |
| Div Yield | N/A | Target | $135.84 |
| Overall | 39 | Value | -- |
| Quality | 52 | Technical | 27 |
No chart data available
Stock Overview
Updated DailyBioNTech SE (BNTX) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $104.14 with a market capitalization of $25.20 billion. The stock is trading in the middle of its 52-week range, demonstrating average quality indicators with a MarketXLS quality score of 52.
Today's trading session shows BNTX with a volume of 627K shares. The stock opened up 0.86% from yesterday's close of $103.91. Current analyst estimates project earnings of $-3.96 per share for this year, with next year targeting $-3.57.
BNTX demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ORTH-CA, OTIC, OTLC, OTLK.
Key investment considerations for BNTX include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 30.4%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 09:53 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BNTX | $104.15 | +0.2% | 626.57K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |